Yanay Yaky

Avg. Two Year Performance

(25%) Avg. Purchase Return
(12%) Compound
63% Avg. Sale Return
28% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%(12%)3%(20%)(25%)
Purchase Success Rate2 of 52 of 53 of 52 of 51 of 5
Average Sale Return9%19%26%31%63%
Sale Success Rate3 of 33 of 32 of 33 of 32 of 3
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 333.59K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--